The use of drugs that inhibit NLRP3 and/or caspase-1 activation, such as metformin and ginsenoside Rg1, has shown a positive effect in the treatment of psoriasis-like lesions by inhibiting Il1b and keratinocyte proliferation (122, 123). The gene discussed is IL1B; the disease is psoriasis.